Mariana Silva Martínez

Dr. Mariana Silva Martínez


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 November 2025 in Research in Veterinary Science
Verified
Journal Article
Closed access
AGAxel E. Guzmán-Cedillo
Axel E. Guzmán-Cedillo
MMMariana Silva Martínez
Mariana Silva Martínez
RPRoxana Pulido-Quintero
Roxana Pulido-Quintero
PRPatricia Rizo
Patricia Rizo
JOJ. Raúl Olmos-Zúñiga
J. Raúl Olmos-Zúñiga

Verified
Journal Article
Open access
PDF file
JOJ. Raul Olmos-Zuniga
J. Raul Olmos-Zuniga
MMMariana Silva Martínez
Mariana Silva Martínez
JLJose Sullivan Lopez-Gonzalez
Jose Sullivan Lopez-Gonzalez
MGMiguel Gaxiola-Gaxiola
Miguel Gaxiola-Gaxiola
ASAvelina Sotres-Vega
Avelina Sotres-Vega
LRLaura Romero Romero
Laura Romero Romero
Polymerised type I collagen (polymerised collagen) and pirfenidone (PFD) reduce fibrosis. However, their use as pharmacological monotherapy for tracheal stenosis (TS) has not been evaluated. This study aimed to evaluate the effects of polymerised collagen or PFD, used either as monotherapy for TS, or in combination with tracheal resection (TRE) on the development of restenosis (RTS), apoptotic body (AB) formation, production of profibrotic proteins, ITGβ1 expression and metalloproteinase (MMP) expression in a rat model of TS. Eighty Wistar rats underwent TS. Forty received monotherapy (treatment A) with: saline solution (SS), mitomycin C (MMC), polymerised collagen, or PFD. The other forty received TRE combined with the pharmacological treatment (treatment B). They were clinically evaluated. Four weeks after treatment, AB formation, ITGβ1, TGF-β, profibrotic proteins, and MMPs expression were assessed in TS tissue and post-TRE tissue. Our findings showed that treatment A with polymerised collagen or PFD did not reverse TS but halted its progression, reduced the expression of profibrotic proteins, ITGβ1 and MMP-9, and increased AB and MMP-1. Treatment B promoted normal tracheal healing and prevented RTS. We conclude that the use of polymerised collagen or PFD as monotherapy does not reverse TS. However, they halt disease progression by modulating the production of profibrotic factors. In combination with TRE, these agents promote favourable tracheal healing and prevent RTS.